<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">Curr Med Res Opin</journal-id><journal-id journal-id-type="iso-abbrev">Curr Med Res Opin</journal-id><journal-id journal-id-type="pmc-domain-id">319</journal-id><journal-id journal-id-type="pmc-domain">nihpa</journal-id><journal-title-group><journal-title>Current medical research and opinion</journal-title></journal-title-group><issn pub-type="ppub">0300-7995</issn><issn pub-type="epub">1473-4877</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>NIHPA Author Manuscripts</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10507676</article-id><article-id pub-id-type="pmcid-ver">PMC10507676.1</article-id><article-id pub-id-type="pmcaid">10507676</article-id><article-id pub-id-type="pmcaiid">10507676</article-id><article-id pub-id-type="manuscript-id">NIHMS1925857</article-id><article-id pub-id-type="pmid">36000252</article-id><article-id pub-id-type="doi">10.1080/03007995.2022.2112874</article-id><article-id pub-id-type="manuscript-id-alternative">NIHMS1925857</article-id><article-id pub-id-type="manuscript-id-alternative">NIHPA1925857</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Development of a Potential Opioid Misuse Measure from Administrative Dispensing Data and Contrasting Opioid Misuse Among Individuals on Long-Term Tramadol, Long-Term Short-Acting Hydrocodone or Long-Term Short-Acting Oxycodone Therapy in Arkansas</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Acharya</surname><given-names initials="M">Mahip</given-names></name><degrees>B.S</degrees><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Hayes</surname><given-names initials="CJ">Corey J.</given-names></name><degrees>PharmD, PhD</degrees><xref rid="A2" ref-type="aff">2</xref><xref rid="A3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Li</surname><given-names initials="C">Chenghui</given-names></name><degrees>PhD</degrees><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Painter</surname><given-names initials="JT">Jacob T.</given-names></name><degrees>PharmD, PhD</degrees><xref rid="A1" ref-type="aff">1</xref><xref rid="A3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Dayer</surname><given-names initials="L">Lindsey</given-names></name><degrees>PharmD</degrees><xref rid="A4" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Martin</surname><given-names initials="BC">Bradley C.</given-names></name><degrees>PharmD, PhD</degrees><xref rid="A1" ref-type="aff">1</xref></contrib></contrib-group><aff id="A1"><label>1</label>Division of Pharmaceutical Evaluation and Policy, University of Arkansas for Medical Sciences, Little Rock, Arkansas</aff><aff id="A2"><label>2</label>Department of Biomedical Informatics, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas</aff><aff id="A3"><label>3</label>Center for Mental Healthcare and Outcomes Research, Central Arkansas Veterans Healthcare Systems, North Little Rock, Arkansas</aff><aff id="A4"><label>4</label>College of Pharmacy, University of Arkansas for Medical Sciences, Little Rock, Arkansas</aff><author-notes><corresp id="CR1">Corresponding Author Bradley C Martin, PharmD, PhD, Division of Pharmaceutical Evaluation and Policy, Department of Pharmacy Practice, University of Arkansas for Medical Sciences, Rahn Building, Room 6259, 4301 W. Markham Street, slot 522, Little Rock, AR-72205, <email>bmartin@uams.edu</email>, <bold>Phone:</bold> (501) 603-1992</corresp><fn fn-type="con" id="FN1"><p id="P1">Author contributions</p><p id="P2">Study conception and design: All authors; data analysis: MA; interpretation of findings: all authors; writing-initial draft: MA and BCM; writing-critical revision: all authors; supervision: BCM; final approval: all authors</p></fn></author-notes><pub-date pub-type="ppub"><month>11</month><year>2022</year></pub-date><pub-date pub-type="epub"><day>28</day><month>8</month><year>2022</year></pub-date><volume>38</volume><issue>11</issue><issue-id pub-id-type="pmc-issue-id">445527</issue-id><fpage>1947</fpage><lpage>1957</lpage><pub-history><event event-type="nihms-submitted"><date><day>30</day><month>08</month><year>2023</year></date></event><event event-type="pmc-release"><date><day>19</day><month>09</month><year>2023</year></date></event><event event-type="pmc-live"><date><day>19</day><month>09</month><year>2023</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-06-15 14:25:13.177"><day>15</day><month>06</month><year>2024</year></date></event></pub-history><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihms-1925857.pdf"/><abstract id="ABS1"><sec id="S1"><title>Purpose:</title><p id="P3">This study sought to: 1) construct and validate a composite potential opioid misuse score and, 2) compare potential opioid misuse among individuals prescribed long-term therapy on tramadol, short-acting hydrocodone or short-acting oxycodone.</p></sec><sec id="S2"><title>Methods:</title><p id="P4">A retrospective cohort study was conducted using Arkansas All-Payer Claims Database (APCD; 2013&#8211;2018) linked to Arkansas Prescription Drug Monitoring Program (PDMP; 2014&#8211;2017) and state death certificate data (2013&#8211;2018). The study subjects were ambulatory, cancer free adults with incident long-term therapy on tramadol, short-acting hydrocodone or short-acting oxycodone. The number of opioid prescribers/pharmacies, cash payment for opioid prescriptions, overlapping prescribers/pharmacies and a composite misuse score (derived from opioid prescribers/pharmacies and cash payment) were assessed in two 180-day windows as potential measures of misuse. The composite score was developed based on associations observed with opioid overdose and opioid-related injuries.</p></sec><sec id="S3"><title>Results:</title><p id="P5">A total of 17,816 (tramadol), 23,660 (hydrocodone) and 4,799 (oxycodone) were included. The composite score had modest discrimination for overdose (c-index =0.65). In the 1<sup>st</sup> 180-day period, the average composite misuse scores were 1.28 (tramadol), 1.93 (hydrocodone) and 2.18 (oxycodone). Compared to long-term hydrocodone, long-term tramadol had lower misuse [IRR (95% CI): 0.75 (0.73&#8211;0.76)], and long-term oxycodone had higher misuse [1.09 (1.07&#8211;1.11)] in adjusted analyses. Qualitatively similar associations were observed for nearly all individual component measures of misuse.</p></sec><sec id="S4"><title>Conclusion:</title><p id="P6">A composite measure of potential opioid misuse had modest levels of discrimination in detecting overdose. In comparison to long-term hydrocodone therapy, long-term oxycodone had higher and tramadol had lower risk of potential opioid misuse.</p></sec></abstract><kwd-group><kwd>tramadol</kwd><kwd>hydrocodone</kwd><kwd>oxycodone</kwd><kwd>long-term opioid therapy</kwd><kwd>opioid misuse</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>